June 24, 2020 / 12:24 PM / 14 days ago

BRIEF-Shanghai Henlius Biotech Enters Amendment To License Agreement With Accord Healthcare

June 24 (Reuters) - Shanghai Henlius Biotech Inc:

* ENTERED AMENDMENT TO LICENSE AGREEMENT WITH ACCORD HEALTHCARE FOR HLX02

* NEW LICENSES WILL BE GRANTED FOR 60MG AND 420MG SPECIFICATIONS OF HLX02

* ACCORD TO PAY CO AN AMOUNT OF MILESTONE FEES NOT EXCEEDING US$3.08 MILLION IN TOTAL Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below